United States Pulmonary Arterial Hypertension (PAH) Medicine Industry 2016 Deep Market Research Report
- QYR587116
- 135 Pages
- June 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Pulmonary Arterial Hypertension (PAH) Medicine market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Pulmonary Arterial Hypertension (PAH) Medicine industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 150 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Pulmonary Arterial Hypertension (PAH) Medicine
1.1.1 Definition of Pulmonary Arterial Hypertension (PAH) Medicine
1.1.2 Specifications of Pulmonary Arterial Hypertension (PAH) Medicine
1.2 Classification of Pulmonary Arterial Hypertension (PAH) Medicine
1.3 Applications of Pulmonary Arterial Hypertension (PAH) Medicine
1.4 Industry Chain Structure of Pulmonary Arterial Hypertension (PAH) Medicine
1.5 Industry Overview of Pulmonary Arterial Hypertension (PAH) Medicine
1.6 Industry Policy Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
1.7 Industry News Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
2 Manufacturing Cost Structure Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
2.1 Bill of Materials (BOM) of Pulmonary Arterial Hypertension (PAH) Medicine
2.2 BOM Price Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
2.3 Labor Cost Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
2.4 Depreciation Cost Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
2.5 Manufacturing Cost Structure Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
2.6 Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
2.7 United States Price, Cost and Gross of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Pulmonary Arterial Hypertension (PAH) Medicine Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Pulmonary Arterial Hypertension (PAH) Medicine Key Manufacturers in 2015
4 Production Analysis of Pulmonary Arterial Hypertension (PAH) Medicine by Regions, Type, and Applications
4.1 United States Production of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016
4.2 United States Production of Pulmonary Arterial Hypertension (PAH) Medicine by Type 2011-2016
4.3 United States Sales of Pulmonary Arterial Hypertension (PAH) Medicine by Applications 2011-2016
4.4 Price Analysis of United States Pulmonary Arterial Hypertension (PAH) Medicine Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
5 Consumption Volume and Consumption Value Analysis of Pulmonary Arterial Hypertension (PAH) Medicine by Regions
5.1 United States Consumption Volume of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016
5.2 United States Consumption Value of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016
5.3 United States Consumption Price Analysis of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016
6 Analysis of Pulmonary Arterial Hypertension (PAH) Medicine Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Pulmonary Arterial Hypertension (PAH) Medicine 2014-2015
6.3 Sales Overview of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
6.4 Supply, Consumption and Gap of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
6.5 Import, Export and Consumption of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
7 Analysis of Pulmonary Arterial Hypertension (PAH) Medicine Industry Key Manufacturers
7.1 Bayer
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 GSK
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Arena
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Actelion
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
…
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Pulmonary Arterial Hypertension (PAH) Medicine Product Types
8.5 Market Share Analysis of Different Pulmonary Arterial Hypertension (PAH) Medicine Price Levels
8.6 Gross Margin Analysis of Different Pulmonary Arterial Hypertension (PAH) Medicine Applications
9 Marketing Trader or Distributor Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
9.1 Marketing Channels Status of Pulmonary Arterial Hypertension (PAH) Medicine
9.2 Traders or Distributors of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
9.4 United States Import, Export and Trade Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
10 Development Trend of Pulmonary Arterial Hypertension (PAH) Medicine Industry 2016-2021
10.1 Capacity and Production Overview of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021
10.2 Production Market Share by Product Types of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021
10.3 Sales and Sales Revenue Overview of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021
10.4 United States Sales of Pulmonary Arterial Hypertension (PAH) Medicine by Applications 2016-2021
10.5 Import, Export and Consumption of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021
11 Industry Chain Suppliers of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
11.1 Major Raw Materials Suppliers of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
11.2 Manufacturing Equipment Suppliers of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
11.3 Major Players of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
11.4 Key Consumers of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
11.5 Supply Chain Relationship Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
12 New Project Investment Feasibility Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
12.1 New Project SWOT Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
12.2 New Project Investment Feasibility Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
13 Conclusion of the United States Pulmonary Arterial Hypertension (PAH) Medicine Industry 2016 Market Research Report
Figure Picture of Pulmonary Arterial Hypertension (PAH) Medicine
Table Product Specifications of Pulmonary Arterial Hypertension (PAH) Medicine
Table Classification of Pulmonary Arterial Hypertension (PAH) Medicine
Figure United States Sales Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Product Types in 2015
Table Applications of Pulmonary Arterial Hypertension (PAH) Medicine
Figure United States Sales Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Applications in 2015
Figure Industry Chain Structure of Pulmonary Arterial Hypertension (PAH) Medicine
Table United States Industry Overview of Pulmonary Arterial Hypertension (PAH) Medicine
Table Industry Policy of Pulmonary Arterial Hypertension (PAH) Medicine
Table Industry News List of Pulmonary Arterial Hypertension (PAH) Medicine
Table Bill of Materials (BOM) of Pulmonary Arterial Hypertension (PAH) Medicine
Table Bill of Materials (BOM) Price of Pulmonary Arterial Hypertension (PAH) Medicine
Table Labor Cost of Pulmonary Arterial Hypertension (PAH) Medicine
Table Depreciation Cost of Pulmonary Arterial Hypertension (PAH) Medicine
Table Manufacturing Cost Structure Analysis of Pulmonary Arterial Hypertension (PAH) Medicine in 2015
Figure Manufacturing Process Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
Table United States Price Analysis of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016 (USD/g)
Table United States Cost Analysis of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016 (USD/g)
Table United States Gross Analysis of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
Table Capacity (Kg) and Commercial Production Date of United States Pulmonary Arterial Hypertension (PAH) Medicine Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers in 2015
Table R&D Status and Technology Source of United States Pulmonary Arterial Hypertension (PAH) Medicine Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Pulmonary Arterial Hypertension (PAH) Medicine Key Manufacturers in 2015
Table United States Production of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016 (Kg)
Table United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016
Figure United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Regions in 2014
Figure United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Regions in 2015
Table United States Production of Pulmonary Arterial Hypertension (PAH) Medicine by Types in 2011-2016 (Kg)
Table United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Type in 2011-2016
Figure United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Type in 2014
Figure United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Type in 2015
Table United States Sales of Pulmonary Arterial Hypertension (PAH) Medicine by Applications 2011-2016 (Kg)
Table United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Applications 2011-2016
Figure United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Applications in 2014
Figure United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Applications in 2015
Table Price Comparison of United States Pulmonary Arterial Hypertension (PAH) Medicine Key Manufacturers in 2015 (USD/g)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
Table United States Consumption Volume of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016 (Kg)
Table United States Consumption Volume Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016
Figure United States Consumption Volume Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Regions in 2014
Figure United States Consumption Volume Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Regions in 2015
Table United States Consumption Value of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016
Figure United States Consumption Value Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Regions in 2014
Figure United States Consumption Value Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Regions in 2015
Table Consumption Price of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016 (USD/g)
Table United States and Major Manufacturers Capacity of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016 (Kg)
Table United States Capacity Market Share of Major Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016 (Kg)
Table United States Production Market Share of Major Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016 (Kg)
Table United States Sales Market Share of Major Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers 2011-2016
Figure United States Capacity (Kg), Production (Kg) and Growth Rate of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
Figure United States Capacity Utilization Rate of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
Figure United States Production Market Share of Major Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers in 2014
Figure United States Production Market Share of Major Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers in 2015
Figure United States Sales Market Share of Major Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers in 2014
Figure United States Sales Market Share of Major Pulmonary Arterial Hypertension (PAH) Medicine Manufacturers in 2015
Figure United States Sales (Kg) and Growth Rate of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
Table United States Supply, Consumption and Gap of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016 (Kg)
Table United States Import, Export and Consumption of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016 (Kg)
Table Price of United States Pulmonary Arterial Hypertension (PAH) Medicine Major Manufacturers 2011-2016 (USD/g)
Table Gross Margin of United States Pulmonary Arterial Hypertension (PAH) Medicine Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016 (M USD)
Table United States Capacity (Kg), Production (Kg), Price (USD/g), Cost (USD/g), Revenue (M USD) and Gross Margin of Pulmonary Arterial Hypertension (PAH) Medicine 2011-2016
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Pulmonary Arterial Hypertension (PAH) Medicine Picture and Specifications of Bayer
Table Pulmonary Arterial Hypertension (PAH) Medicine Capacity (Kg), Production (Kg), Price (USD/g), Cost (USD/g), Gross (USD/g), Revenue (M USD) and Gross Margin of Bayer 2011-2016
Figure Pulmonary Arterial Hypertension (PAH) Medicine Capacity (Kg), Production (Kg) and Growth Rate of Bayer 2011-2016
Figure Pulmonary Arterial Hypertension (PAH) Medicine Production (Kg) and United States Market Share of Bayer 2011-2016
Table Bayer Pulmonary Arterial Hypertension (PAH) Medicine SWOT Analysis
Table GSK Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Pulmonary Arterial Hypertension (PAH) Medicine Picture and Specifications of GSK
Table Pulmonary Arterial Hypertension (PAH) Medicine Capacity (Kg), Production (Kg), Price (USD/g), Cost (USD/g), Gross (USD/g), Revenue (M USD) and Gross Margin of GSK 2011-2016
Figure Pulmonary Arterial Hypertension (PAH) Medicine Capacity (Kg), Production (Kg) and Growth Rate of GSK 2011-2016
Figure Pulmonary Arterial Hypertension (PAH) Medicine Production (Kg) and United States Market Share of GSK 2011-2016
Table GSK Pulmonary Arterial Hypertension (PAH) Medicine SWOT Analysis
Table Arena Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Pulmonary Arterial Hypertension (PAH) Medicine Picture and Specifications of Arena
Table Pulmonary Arterial Hypertension (PAH) Medicine Capacity (Kg), Production (Kg), Price (USD/g), Cost (USD/g), Gross (USD/g), Revenue (M USD) and Gross Margin of Arena 2011-2016
Figure Pulmonary Arterial Hypertension (PAH) Medicine Capacity (Kg), Production (Kg) and Growth Rate of Arena 2011-2016
Figure Pulmonary Arterial Hypertension (PAH) Medicine Production (Kg) and United States Market Share of Arena 2011-2016
Table Arena Pulmonary Arterial Hypertension (PAH) Medicine SWOT Analysis
Table Actelion Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Pulmonary Arterial Hypertension (PAH) Medicine Picture and Specifications of Actelion
Table Pulmonary Arterial Hypertension (PAH) Medicine Capacity (Kg), Production (Kg), Price (USD/g), Cost (USD/g), Gross (USD/g), Revenue (M USD) and Gross Margin of Actelion 2011-2016
Figure Pulmonary Arterial Hypertension (PAH) Medicine Capacity (Kg), Production (Kg) and Growth Rate of Actelion 2011-2016
Figure Pulmonary Arterial Hypertension (PAH) Medicine Production (Kg) and United States Market Share of Actelion 2011-2016
Table Actelion Pulmonary Arterial Hypertension (PAH) Medicine SWOT Analysis
Table Pulmonary Arterial Hypertension (PAH) Medicine Price by Regions 2011-2016
Table Pulmonary Arterial Hypertension (PAH) Medicine Price by Product Types 2011-2016
Table Pulmonary Arterial Hypertension (PAH) Medicine Price by Companies 2011-2016
Table Pulmonary Arterial Hypertension (PAH) Medicine Gross Margin by Companies 2011-2016
Table Price Comparison of Pulmonary Arterial Hypertension (PAH) Medicine by Regions 2011-2016 (USD/g)
Table Price of Different Pulmonary Arterial Hypertension (PAH) Medicine Product Types (USD/g)
Table Market Share of Different Pulmonary Arterial Hypertension (PAH) Medicine Price Level
Table Gross Margin of Different Pulmonary Arterial Hypertension (PAH) Medicine Applications
Table Marketing Channels Status of Pulmonary Arterial Hypertension (PAH) Medicine
Table Traders or Distributors of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Pulmonary Arterial Hypertension (PAH) Medicine (USD/g) in 2015
Table United States Import, Export, and Trade of Pulmonary Arterial Hypertension (PAH) Medicine (Kg)
Figure United States Capacity (Kg), Production (Kg) and Growth Rate of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021
Figure United States Capacity Utilization Rate of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021
Table United States Pulmonary Arterial Hypertension (PAH) Medicine Production by Type 2016-2021 (Kg)
Table United States Pulmonary Arterial Hypertension (PAH) Medicine Production Market Share by Type 2016-2021
Figure United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Type in 2021
Figure United States Sales (Kg) and Growth Rate of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021
Figure United States Sales of Pulmonary Arterial Hypertension (PAH) Medicine by Applications 2016-2021 (Kg)
Table United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Applications 2016-2021
Figure United States Production Market Share of Pulmonary Arterial Hypertension (PAH) Medicine by Applications in 2021
Table United States Production, Import, Export and Consumption of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021 (Kg)
Table United States Production (Kg), Price (USD/g), Cost (USD/g), Revenue (M USD) and Gross Margin of Pulmonary Arterial Hypertension (PAH) Medicine 2016-2021
Table Major Raw Materials Suppliers of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
Table Manufacturing Equipment Suppliers of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
Table Major Players of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
Table Key Consumers of Pulmonary Arterial Hypertension (PAH) Medicine with Contact Information
Table Supply Chain Relationship Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
Table New Project SWOT Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
Table New Project Investment Feasibility Analysis of Pulmonary Arterial Hypertension (PAH) Medicine
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
